Tag: SOLVE-CRT
US FDA approves “world’s first and only” leadless LVEP device for...
EBR Systems has received US Food and Drug Administration (FDA) approval of the WiSE system—marking what the company describes as a significant leap forward...
HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat...
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronisation therapy (CRT) among patients who were not able to be...
EBR Systems initiates global trial of world’s only wireless CRT pacing...
EBR Systems has announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronisation Therapy) clinical...